Device / Technology News

RSS

New computer-based system can distinguish similar secondary tumours

A new computer-based system discussed in the International Journal of Healthcare Technology and Management can distinguish between apparently similar secondary tumours and allow a cancer specialist to trace the metastases back to the site of the original cancer in the patient's body.

5 Apr 2011

Modified pulse oximeter detects risk of cardiovascular disease during sleep

A specially customised pulse oximeter attached to the finger can be used to detect changes in heart and vessel function while you sleep, and this simple technique can even identify patients at increased risk of cardiovascular disease, reveals research from the University of Gothenburg, Sweden.

5 Apr 2011

More physicians opting for salaries, other health care industry news

Even as a girl, Dr. Kate Dewar seemed destined to inherit the small-town medical practice of her grandfather and father. ... But when she finishes residency this summer, Dr. Dewar, 31, will not be going home. Instead, she will take a job as a salaried emergency room doctor at a hospital in Elmira, N.Y., two hours away.

5 Apr 2011

Agilent launches SureCycler 8800 thermal cycler

Agilent Technologies, Inc. today introduced the Agilent SureCycler 8800, a full-featured thermal cycler that eliminates the need to choose between popular features of other major PCR instruments.

5 Apr 2011

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

5 Apr 2011

PLC's RenalGuard REMEDIAL II trial against CIN presented at ACC.11

PLC Systems Inc., a company focused on innovative medical device technologies, announced that final results from the REMEDIAL II investigator-sponsored clinical trial of RenalGuard in Italy were presented today.

5 Apr 2011

Positive outcomes from Medtronic's Resolute drug-eluting stent against coronary artery disease

Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology - demonstrate that the Resolute drug-eluting stent from Medtronic, Inc., provides a positive and persistent treatment effect for a wide variety of patients with coronary artery disease.

5 Apr 2011

VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

VisualSonics Inc., a leader in real time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., is demonstrating the recently announced Vevo LAZR Photoacoustics Imaging system at the American Association of Cancer Research's annual conference.

5 Apr 2011

CryoLife files PerClot IDE with FDA to initiate clinical trials in the U.S.

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has filed an IDE with the United States Food and Drug Administration to begin clinical trials for the purpose of obtaining Pre-Market Approval to distribute PerClot in the U.S. to control bleeding during surgical procedures or following traumatic injuries.

5 Apr 2011

Caliper introduces novel fluorescent imaging agent for pre-clinical research

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery, life sciences research and molecular diagnostics, today announced the launch of XenoLight RediJect COX-2 Probe, a novel fluorescent imaging agent for pre-clinical research that specifically detects the cyclooxygenase-2 biomarker noninvasively in live animal models as well as in ex vivo tissue analysis applications.

5 Apr 2011

Medical industry veteran set to play key role as Microvisk gears up to launch Smartstrip®

Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, today announced that it has strengthened its Board with the appointment of medical industry veteran, Bill Moffitt, as Chairman and Peter Whitehouse as CFO.

4 Apr 2011

Novel biomarker test accurately detects proteins secreted from asbestos-related tumors

Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6.

4 Apr 2011

VA's electronic health record system to be updated

The Veterans Affairs Department, which operates one of the largest medical systems in the world, is moving ahead with plans to modernize its electronic health- records using open-source software. ... U.S. hospitals and medical practices are preparing to digitize their health records, often using commercial products. ...

4 Apr 2011

Sofie Biosciences launches GENISYS4 benchtop small animal PET system

Sofie Biosciences, a developer of molecular imaging systems and agents, announced the launch of GENISYS4, their new benchtop small animal PET system. Introduced today at the 2011 American Association for Cancer Research Annual Meeting, this compact, preclinical multimodality PET system provides researchers with the ability to non-invasively visualize and measure the biology of disease and therapeutic response over the course of a study.

4 Apr 2011

Axxora.com to distribute TGR's new ELISAONE technology assay reagents in the US and South America

TGR BioSciences, a leading global provider of advanced cell based assay technologies in the fields of cancer, kinase and GPCR research, is extremely pleased to announce a distribution partnership with Axxora.com of San Diego, CA, US, a leading online global market place resource for innovative and high quality Life Science research reagents.

4 Apr 2011

Coronary computed tomographic angiography to evaluate acute chest pain reduces hospital admissions

Hospital admissions at Stony Brook University Medical Center on Long Island were significantly reduced when using coronary computed tomographic angiography (CCTA) to evaluate patients presenting in the emergency department (ED) with acute chest pain (ACP), according to research results presented during a scientific session at the American College of Cardiology's 60th Annual Scientific Session and Expo in New Orleans on April 3.

4 Apr 2011

Pronto to distribute Signal's Myeloma Prognostic Risk Signature test in Israel

Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.

4 Apr 2011

Hospira seeks FDA 510(k) clearance for Symbiq infusion system modifications

Hospira, Inc., a leading provider of clinical information and medication delivery technologies, today announced that the company has submitted a 510(k) application with the U.S. Food and Drug Administration (FDA) for modifications to the Symbiq™ infusion system. The submission is one of the first developed to align with the recent FDA draft guidance for 510(k) infusion pump clearances.

4 Apr 2011

FDA approves St. Jude Medical's Safire BLU and Therapy Cool Path irrigated ablation catheters

St. Jude Medical, Inc., a global medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) approval of two new irrigated ablation catheters - the Safire BLU™ Bi-directional Irrigated Ablation Catheter and the Therapy™ Cool Path™ bi-directional ablation catheter.

4 Apr 2011

AtlantiCare to implement MEDai's Risk Navigator predictive analytic solution

AtlantiCare, the largest health system in southeastern New Jersey, will allow its healthcare providers to better manage patient populations and track clinical and financial objectives with quality-focused tools from Elsevier/MEDai, a leading provider of predictive analytic solutions.

4 Apr 2011

Device / Technology News

New computer-based system can distinguish similar secondary tumours

Modified pulse oximeter detects risk of cardiovascular disease during sleep

More physicians opting for salaries, other health care industry news

Agilent launches SureCycler 8800 thermal cycler

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

PLC's RenalGuard REMEDIAL II trial against CIN presented at ACC.11

Positive outcomes from Medtronic's Resolute drug-eluting stent against coronary artery disease

VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

CryoLife files PerClot IDE with FDA to initiate clinical trials in the U.S.

Caliper introduces novel fluorescent imaging agent for pre-clinical research

Medical industry veteran set to play key role as Microvisk gears up to launch Smartstrip®

Novel biomarker test accurately detects proteins secreted from asbestos-related tumors

VA's electronic health record system to be updated

Sofie Biosciences launches GENISYS4 benchtop small animal PET system

Axxora.com to distribute TGR's new ELISAONE technology assay reagents in the US and South America

Coronary computed tomographic angiography to evaluate acute chest pain reduces hospital admissions

Pronto to distribute Signal's Myeloma Prognostic Risk Signature test in Israel

Hospira seeks FDA 510(k) clearance for Symbiq infusion system modifications

FDA approves St. Jude Medical's Safire BLU and Therapy Cool Path irrigated ablation catheters

AtlantiCare to implement MEDai's Risk Navigator predictive analytic solution

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News